Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Pflugers Arch
2005 Dec 01;4513:445-53. doi: 10.1007/s00424-005-1477-4.
Show Gene links
Show Anatomy links
PPARgamma agonists do not directly enhance basal or insulin-stimulated Na(+) transport via the epithelial Na(+) channel.
Nofziger C
,
Chen L
,
Shane MA
,
Smith CD
,
Brown KK
,
Blazer-Yost BL
.
???displayArticle.abstract???
Selective agonists of peroxisome proliferator-activated receptor gamma (PPARgamma) are anti-diabetic drugs that enhance cellular responsiveness to insulin. However, in some patients, fluid retention, plasma volume expansion, and edema have been observed. It is well established that insulin regulates Na(+) reabsorption via the epithelial sodium channel (ENaC) located in the distal tubule. Therefore, we hypothesized that these agonists may positively modulate insulin-stimulated ENaC activity leading to increased Na(+) reabsorption and fluid retention. Using electrophysiological techniques, dose-response curves for insulin-mediated Na(+) transport in the A6, M-1, and mpkCCD(cl4) cell lines were performed. Each line demonstrated hormone efficacy within physiological concentration ranges and, therefore, can be used to monitor clinically relevant effects of pharmacological agents which may affect electrolyte transport. Immunodetection and quantitative PCR analyses showed that each cell line expresses viable and functional PPARgamma receptors. Despite this finding, two PPARgamma agonists, pioglitazone and GW7845 did not directly enhance basal or insulin-stimulated Na(+) flux via ENaC, as shown by electrophysiological methodologies. These studies provide important results, which eliminate insulin-mediated ENaC activation as a candidate mechanism underlying the fluid retention observed with PPARgamma agonist use.
Baxendale-Cox,
Insulin increases sodium (Na+) channel density in A6 epithelia: implications for expression of hypertension.
1999, Pubmed
Baxendale-Cox,
Insulin increases sodium (Na+) channel density in A6 epithelia: implications for expression of hypertension.
1999,
Pubmed
Bens,
Corticosteroid-dependent sodium transport in a novel immortalized mouse collecting duct principal cell line.
1999,
Pubmed
Blazer-Yost,
Insulin-stimulated trafficking of ENaC in renal cells requires PI 3-kinase activity.
2003,
Pubmed
,
Xenbase
Buchanan,
Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect.
1995,
Pubmed
Calnek,
Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells.
2003,
Pubmed
Chang,
Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1.
1996,
Pubmed
Cheatham,
Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation.
1994,
Pubmed
DeFronzo,
The effect of insulin on renal sodium metabolism. A review with clinical implications.
1981,
Pubmed
DeFronzo,
The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man.
1975,
Pubmed
Faletti,
sgk: an essential convergence point for peptide and steroid hormone regulation of ENaC-mediated Na+ transport.
2002,
Pubmed
,
Xenbase
Fang,
Angiotensin receptor blockade blunts hyperinsulinemia-induced hypertension in rats.
1998,
Pubmed
Gardiner,
Regional hemodynamic effects of the N-(2-benzoylphenyl)-L-tyrosine peroxisome proliferator-activated receptor-gamma ligand, GI 262570 [(S)-2-(2-benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4-yl)ethoxy]phenyl]propionic acid], in conscious rats.
2004,
Pubmed
Guan,
Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature.
2001,
Pubmed
Guan,
Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans.
1997,
Pubmed
Guan,
Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.
2001,
Pubmed
Hong,
PPARgamma activation enhances cell surface ENaCalpha via up-regulation of SGK1 in human collecting duct cells.
2003,
Pubmed
Hsueh,
Peroxisome proliferator-activated receptor-gamma in the renal mesangium.
2002,
Pubmed
Kotchen,
Effect of pioglitazone on vascular reactivity in vivo and in vitro.
1996,
Pubmed
Lehmann,
An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).
1995,
Pubmed
May,
Early effect of aldosterone on the rate of synthesis of the epithelial sodium channel alpha subunit in A6 renal cells.
1997,
Pubmed
,
Xenbase
McFarlane,
Insulin resistance and cardiovascular disease.
2001,
Pubmed
Motojima,
Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner.
1998,
Pubmed
Nakhoul,
Regulation of sodium transport in M-1 cells.
1998,
Pubmed
Nesto,
Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
2003,
Pubmed
Parulkar,
Nonhypoglycemic effects of thiazolidinediones.
2001,
Pubmed
Reaven,
Insulin resistance: a chicken that has come to roost.
1999,
Pubmed
Sharma,
Insulin resistance in young salt-sensitive normotensive subjects.
1993,
Pubmed
Shimkets,
Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel.
1994,
Pubmed
Song,
Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats.
2004,
Pubmed
Stoos,
Characterization of a mouse cortical collecting duct cell line.
1991,
Pubmed
Takagawa,
Long-term fructose feeding impairs vascular relaxation in rat mesenteric arteries.
2001,
Pubmed
Willson,
Peroxisome proliferator-activated receptor gamma and metabolic disease.
2001,
Pubmed
Yang,
Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney.
1999,
Pubmed
Yeh,
The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin- and contraction-activated hexose transport.
1995,
Pubmed
